<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs (miRNAs) are essential for regulating <z:mpath ids='MPATH_458'>normal</z:mpath> embryonic development and <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report that miR-17-5p, an oncofoetal miRNA, is a key regulator of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression </plain></SENT>
<SENT sid="2" pm="."><plain>We show that miR-17-5p is an oncogenic miRNA that regulates <z:mp ids='MP_0002006'>tumorigenesis</z:mp> and progression by targeting the gene encoding P130 and subsequently activating the Wnt/Î²-catenin pathway </plain></SENT>
<SENT sid="3" pm="."><plain>Using specimens from two large cohorts of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients, we found that patients whose <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> had high miR-17-5p expression had shorter overall survival rates but showed a better response to adjuvant chemotherapy than did patients whose <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> had low miRNA expression </plain></SENT>
<SENT sid="4" pm="."><plain>We also observed a strong inverse correlation between miR-17-5p and P130 expression </plain></SENT>
<SENT sid="5" pm="."><plain>The current findings suggest that miR-17-5p is a crucial determinant of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression </plain></SENT>
</text></document>